Epidemiology of Chlamydia trachomatis in Canada: systematic review and meta-analysis, 1981–2025
Sexual Health · 17.08.2026 · 23 (4)
DOI: 10.1071/sh26066 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Sexual Health, online erschienen am 16.07.2026. Verfasst von Mahmoud Yousef und 5 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar. Hauptthemen laut MEDLINE: Chlamydia Infections, Chlamydia trachomatis. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
This study aimed to systematically review and synthesize evidence on Chlamydia trachomatis prevalence in Canada, describe epidemiological patterns across populations and anatomical sites, and assess associations with prevalence.
Methods
A systematic review of Chlamydia trachomatis prevalence studies was conducted and reported according to PRISMA guidelines. Random-effects meta-analyses generated pooled mean prevalence estimates, and meta-regression analyses explored epidemiological and methodological predictors of prevalence variation.
Results
A total of 169 publications were included, contributing 437 prevalence measures spanning 1981–2025. The pooled mean prevalence in the general population was 4.4% (95% CI: 3.6–5.2%) for current urogenital infection and 50.3% (95% CI: 44.5–56.1%) for ever infection. Among men who have sex with men and transgender people, prevalence estimates were 1.8% (95% CI: 0.6–3.5%) for urogenital infection, 6.6% (95% CI: 3.7–10.1%) for anorectal infection and 0.7% (95% CI: 0.0–2.1%) for oropharyngeal infection. Prevalence was substantially higher among symptomatic populations, reaching 18.6% (95% CI: 9.3–30.2%) in women and 24.3% (95% CI: 13.7–36.7%) in men. Meta-regression analyses explained >40% of the observed variation in prevalence, indicating that prevalence was approximately 30% lower among individuals aged ≥25 years compared with those aged <25 years, with no significant sex differences. Prevalence declined over time at a relative rate of 3% per year.
Conclusions
Chlamydia trachomatis prevalence in Canada is comparable to global levels. The ongoing persistence of infection underscores the need to enhance public health responses and expand investment in vaccine development as a cornerstone of long-term prevention and control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar.
- Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, NY, USA.
- Department of Public Health, College of Health Sciences, QU Health Sector, Qatar University, Doha, Qatar.
- College of Health and Life Sciences, Hamad bin Khalifa University, Doha, Qatar.
ORCID-Profile: Laith J Abu-Raddad
Zitieren
APA
Yousef, M., Rob, M., Ageeb, R. A., El-Khoury, R., Harfouche, M., & Abu-Raddad, L. J. (2026). Epidemiology of Chlamydia trachomatis in Canada: systematic review and meta-analysis, 1981–2025. Sexual Health, 23(4). https://doi.org/10.1071/sh26066
Vancouver
Yousef M, Rob M, Ageeb RA, El-Khoury R, Harfouche M, Abu-Raddad LJ. Epidemiology of Chlamydia trachomatis in Canada: systematic review and meta-analysis, 1981–2025. Sexual Health. 2026;23(4). doi:10.1071/sh26066
BibTeX
@article{Yousef2026,
author = {Yousef, Mahmoud and Rob, Mlaak and Ageeb, Rwedah A and El-Khoury, Rayane and Harfouche, Manale and Abu-Raddad, Laith J},
title = {Epidemiology of Chlamydia trachomatis in Canada: systematic review and meta-analysis, 1981–2025},
journal = {Sexual Health},
year = {2026},
volume = {23},
number = {4},
doi = {10.1071/sh26066}
}
EUVIMED